242 related articles for article (PubMed ID: 28940083)
1. Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis.
Hu Q; Zhang F; Teng W; Hao F; Zhang J; Yin M; Wang N
J Neurol; 2018 Jan; 265(1):1-11. PubMed ID: 28940083
[TBL] [Abstract][Full Text] [Related]
2. Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison.
Zhu LN; Chen D; Xu D; Tan G; Wang HJ; Liu L
Seizure; 2017 Oct; 51():121-132. PubMed ID: 28854405
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of antiepileptic drugs in the adjunctive treatment of refractory partial-onset seizures: Meta-analysis of pivotal trials.
Slater J; Chung S; Huynh L; Duh MS; Gorin B; McMicken C; Ziemann A; Isojarvi J
Epilepsy Res; 2018 Jul; 143():120-129. PubMed ID: 29784458
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Tolerability of Antiepileptic Drugs in Patients with Focal Epilepsy: Systematic Review and Network Meta-analyses.
Campos MS; Ayres LR; Morelo MR; Marques FA; Pereira LR
Pharmacotherapy; 2016 Dec; 36(12):1255-1271. PubMed ID: 27779771
[TBL] [Abstract][Full Text] [Related]
5. Antiepileptic drug monotherapy for epilepsy in the elderly: A systematic review and network meta-analysis.
Lattanzi S; Trinka E; Del Giovane C; Nardone R; Silvestrini M; Brigo F
Epilepsia; 2019 Nov; 60(11):2245-2254. PubMed ID: 31608438
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Brigo F; Bragazzi NL; Nardone R; Trinka E
Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
[TBL] [Abstract][Full Text] [Related]
7. Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy.
Li-Na Z; Deng C; Hai-Jiao W; Da X; Ge T; Ling L
Epilepsy Res; 2018 Jan; 139():60-72. PubMed ID: 29197667
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy.
Otoul C; Arrigo C; van Rijckevorsel K; French JA
Clin Neuropharmacol; 2005; 28(2):72-8. PubMed ID: 15795549
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and safety of the newer antiepileptic drugs as adjunctive treatment in adults with refractory partial-onset epilepsy: a meta-analysis of randomized placebo-controlled trials.
Gao L; Xia L; Zhao FL; Li SC
Epilepsy Res; 2013 Jan; 103(1):31-44. PubMed ID: 22776828
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis.
Lattanzi S; Zaccara G; Giovannelli F; Grillo E; Nardone R; Silvestrini M; Trinka E; Brigo F
Acta Neurol Scand; 2019 Jan; 139(1):33-41. PubMed ID: 30194755
[TBL] [Abstract][Full Text] [Related]
11. Tolerability of new antiepileptic drugs: a network meta-analysis.
Zaccara G; Giovannelli F; Giorgi FS; Franco V; Gasparini S; Benedetto U
Eur J Clin Pharmacol; 2017 Jul; 73(7):811-817. PubMed ID: 28378057
[TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and tolerability of anti-epileptic drugs for refractory focal epilepsy: systematic review and network meta-analysis reveals the need for long term comparator trials.
Bodalia PN; Grosso AM; Sofat R; Macallister RJ; Smeeth L; Dhillon S; Casas JP; Wonderling D; Hingorani AD
Br J Clin Pharmacol; 2013 Nov; 76(5):649-67. PubMed ID: 23351090
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive brivaracetam for patients with refractory partial seizures: A meta-analysis of randomized placebo-controlled trials.
Ma J; Huang S; You C
Epilepsy Res; 2015 Aug; 114():59-65. PubMed ID: 26088886
[TBL] [Abstract][Full Text] [Related]
14. Network meta-analysis of antiepileptic drugs in focal drug-resistant epilepsy.
Hu TY; Wang HQ; Zhang WP; Tian RF; Lei GS; Deng YC; Xing JL
Epilepsy Res; 2020 Nov; 167():106433. PubMed ID: 32866761
[TBL] [Abstract][Full Text] [Related]
15. Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: a phase III randomized, double-blind, placebo-controlled trial.
Biton V; Berkovic SF; Abou-Khalil B; Sperling MR; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):57-66. PubMed ID: 24446953
[TBL] [Abstract][Full Text] [Related]
16. Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal.
Craig D; Rice S; Paton F; Fox D; Woolacott N
Pharmacoeconomics; 2013 Feb; 31(2):101-10. PubMed ID: 23341194
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of retigabine and other adjunctive treatments for refractory partial epilepsy: a systematic review and indirect comparison.
Martyn-St James M; Glanville J; McCool R; Duffy S; Cooper J; Hugel P; Lane PW
Seizure; 2012 Nov; 21(9):665-78. PubMed ID: 22902288
[TBL] [Abstract][Full Text] [Related]
18. Prospective audits with newer antiepileptic drugs in focal epilepsy: insights into population responses?
Brodie MJ; Kelly K; Stephen LJ
Epilepsy Behav; 2014 Feb; 31():73-6. PubMed ID: 24361766
[TBL] [Abstract][Full Text] [Related]
19. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
20. Long-term Effectiveness of Antiepileptic Drug Monotherapy in Partial Epileptic Patients: A 7-year Study in an Epilepsy Center in China.
Zhu F; Lang SY; Wang XQ; Shi XB; Ma YF; Zhang X; Chen YN; Zhang JT
Chin Med J (Engl); 2015 Nov; 128(22):3015-22. PubMed ID: 26608980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
